Top compounds associated with response to ACTL6B


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.057 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC 0.078 0.04
mRNA tivozanib CTRPv2 pan-cancer AAC 0.024 0.5
mRNA tosedostat CTRPv2 pan-cancer AAC 0.038 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.071 0.03
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.12 0.003
mRNA triptolide CTRPv2 pan-cancer AAC 0.011 0.8
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.12 0.02
Download CSV